Exemplos de uso de Require dose adjustment em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Conditions that require dose adjustments.
The administration of Keppra to patients with renal impairment may require dose adjustment.
This may require dose adjustment of hydrocortisone.
Therefore, the combination of these may require dose adjustment.
This medicine may require dose adjustment by your doctor.
This time delay must be taken into account when Exalief is being used just prior to orin combination with other medicines that require dose adjustment when co-administered with Exalief.
Examples of other CYP3A4 substrates which may require dose adjustment and/or clinical monitoring include calcium channel blockers(e.g. nifedipine), and trazodone.
A number of substances affect glucose metabolism and may require dose adjustment of Xultophy.
Concomitant use of PDE-5 inhibitors with INTELENCE may require dose adjustment of the PDE-5 inhibitor to attain the desired clinical effect.
This time delay must be taken into account when Zebinix is being used just prior to orin combination with other medicinal products that require dose adjustment when co-administered with Zebinix.
CYP3A substrates evaluated in drug interaction studies which may require dose adjustment and/or clinical monitoring include(see Table 2) cyclosporine, tacrolimus, amlodipine, rilpivirine and alprazolam.
However, these adverse reactions(abdominal pain, diarrhoea, nausea and fatigue) are mild or moderate, transient,of short duration but may require dose adjustment or additional concomitant medicinal products.
These specific medicines may require dose adjustment by your doctor.
Caution is advised whenever VIRACEPT is co- administered with medicinal products which are inducers or inhibitors and/ or substrates of CYP3A4;such combinations may require dose adjustment see also sections 4.3, 4.5 and 4.8.
However, these adverse reactions(abdominal pain, diarrhoea, nausea and fatigue) are mild or moderate, transient,of short duration but may require dose adjustment or additional concomitant medicinal products, see section 4.2. Fatigue has been reported as very common.
Co-administration of Viekirax with or without dasabuvir can decrease exposures of medicinal products that are metabolized by CYP2C19(e.g. lansoprazole, esomeprazole, s-mephenytoin),which may require dose adjustment/clinical monitoring.
Concomitant use of CYP3A4 substrates andmodulators may require dose adjustment see section 4.5.
Combination with other medicinal products: Caution is advised whenever VIRACEPT is co- administered with agents that are inducers or inhibitors and/or substrates of CYP3A4;such combinations may require dose adjustment see also sections 4.3 and 4.8.
A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine.
Medicinal products with a narrow therapeutic range that are substrates for P-gp(e.g. colchicine, dabigatran etexilate, digoxin)should be used with caution when administered concomitantly with Xtandi and may require dose adjustment to maintain optimal plasma concentrations.
PNH patients receiving Soliris therapy should be similarly monitored for intravascular haemolysis by measuring LDH levels,and may require dose adjustment within the recommended 14±2 day dosing schedule during the maintenance phase up to every.
Interactions requiring dose adjustment of Vitekta.
There is insufficient information to determine if Lojuxta requires dose adjustment in other races.
Patients requiring dose adjustments of abacavir or lamivudine should take the medicines separately.
Toxicity was characterized by stomatitis and myelodepression and required dose adjustments in 30% of patients.
Kivexa is a fixed-dose tablet andshould not be prescribed for patients requiring dose adjustments.
The interactions in the table are presented in the following order:contraindications, those requiring dose adjustment and careful clinical and/or biological monitoring, and finally those that have no significant pharmacokinetic interaction but may be of clinical interest in this therapeutic field.
EVOTAZ should not be initiated in patients with creatinine clearance less than 70 ml/min if any co-administered agent(e.g. emtricitabine, lamivudine,tenofovir disoproxil fumarate or adefovir) requires dose adjustment based on creatinine clearance see sections 4.4, 4.8 and 5.2.
Tybost should not be initiated in patients with creatinine clearance less than 70 ml/min if any co-administered agent(e.g. emtricitabine, lamivudine,tenofovir disoproxil fumarate, or adefovir) requires dose adjustment based on creatinine clearance.
Tybost should not be initiated in patients with creatinine clearance less than 70 ml/min if one ormore co-administered agent requires dose adjustment based on creatinine clearance e.g. emtricitabine, lamivudine, tenofovir disoproxil fumarate or adefovir.